BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 29238041)

  • 1. FoxO1 is a regulator of MHC-II expression and anti-tumor effect of tumor-associated macrophages.
    Yang JB; Zhao ZB; Liu QZ; Hu TD; Long J; Yan K; Lian ZX
    Oncogene; 2018 Mar; 37(9):1192-1204. PubMed ID: 29238041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Zinc finger protein ZBTB20 is an independent prognostic marker and promotes tumor growth of human hepatocellular carcinoma by repressing FoxO1.
    Kan H; Huang Y; Li X; Liu D; Chen J; Shu M
    Oncotarget; 2016 Mar; 7(12):14336-49. PubMed ID: 26893361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NK3 homeobox 1 (NKX3.1) up-regulates forkhead box O1 expression in hepatocellular carcinoma and thereby suppresses tumor proliferation and invasion.
    Jiang J; Liu Z; Ge C; Chen C; Zhao F; Li H; Chen T; Yao M; Li J
    J Biol Chem; 2017 Nov; 292(47):19146-19159. PubMed ID: 28972178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Forkhead Box O1 Regulates Macrophage Polarization Following Staphylococcus aureus Infection: Experimental Murine Data and Review of the Literature.
    Wang YC; Ma HD; Yin XY; Wang YH; Liu QZ; Yang JB; Shi QH; Sun B; Gershwin ME; Lian ZX
    Clin Rev Allergy Immunol; 2016 Dec; 51(3):353-369. PubMed ID: 26924010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotherapy resistance and metastasis-promoting effects of thyroid hormone in hepatocarcinoma cells are mediated by suppression of FoxO1 and Bim pathway.
    Chi HC; Chen SL; Cheng YH; Lin TK; Tsai CY; Tsai MM; Lin YH; Huang YH; Lin KH
    Cell Death Dis; 2016 Aug; 7(8):e2324. PubMed ID: 27490929
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3.
    Chang YC; Chen TC; Lee CT; Yang CY; Wang HW; Wang CC; Hsieh SL
    Blood; 2008 May; 111(10):5054-63. PubMed ID: 18349319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of RIP140 suppresses the malignant potential of hepatocellular carcinoma by inhibiting NF‑κB‑mediated alternative polarization of macrophages.
    Hu YC; Yi ZJ; Zhou Y; Li PZ; Liu ZJ; Duan SG; Gong JP
    Oncol Rep; 2017 May; 37(5):2971-2979. PubMed ID: 28393222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aquaporin 9 inhibits hepatocellular carcinoma through up-regulating FOXO1 expression.
    Li CF; Zhang WG; Liu M; Qiu LW; Chen XF; Lv L; Mei ZC
    Oncotarget; 2016 Jul; 7(28):44161-44170. PubMed ID: 27329843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
    Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
    Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcription factor HBP1 is a direct anti-cancer target of transcription factor FOXO1 in invasive oral cancer.
    Chan CY; Huang SY; Sheu JJ; Roth MM; Chou IT; Lien CH; Lee MF; Huang CY
    Oncotarget; 2017 Feb; 8(9):14537-14548. PubMed ID: 28099936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA‑300 induces the proliferation of liver cancer by downregulating transcription factor FOXO1.
    Chang Y; Zhou C; Fan L; Qiu G; Wang G; Wei G; Chang X; Li X
    Oncol Rep; 2018 Dec; 40(6):3561-3572. PubMed ID: 30272296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocellular carcinoma-derived FOXO1 inhibits tumor progression by suppressing IL-6 secretion from macrophages.
    Cui X; Zhao H; Wei S; Du Q; Dong K; Yan Y; Geller DA
    Neoplasia; 2023 Jun; 40():100900. PubMed ID: 37058885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Goserelin promotes the apoptosis of epithelial ovarian cancer cells by upregulating forkhead box O1 through the PI3K/AKT signaling pathway.
    Zhang N; Qiu J; Zheng T; Zhang X; Hua K; Zhang Y
    Oncol Rep; 2018 Mar; 39(3):1034-1042. PubMed ID: 29286125
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HCV core protein-induced upregulation of microRNA-196a promotes aberrant proliferation in hepatocellular carcinoma by targeting FOXO1.
    Xu H; Li G; Yue Z; Li C
    Mol Med Rep; 2016 Jun; 13(6):5223-9. PubMed ID: 27108614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoliposome C6-Ceramide Increases the Anti-tumor Immune Response and Slows Growth of Liver Tumors in Mice.
    Li G; Liu D; Kimchi ET; Kaifi JT; Qi X; Manjunath Y; Liu X; Deering T; Avella DM; Fox T; Rockey DC; Schell TD; Kester M; Staveley-O'Carroll KF
    Gastroenterology; 2018 Mar; 154(4):1024-1036.e9. PubMed ID: 29408569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of MHC class II gene expression in uveal melanoma cells is due to methylation of the CIITA gene or an upstream activator.
    Radosevich M; Jager M; Ono SJ
    Exp Mol Pathol; 2007 Feb; 82(1):68-76. PubMed ID: 16650406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of the hypoxia-Nrp-1 axis in the activation of M2-like tumor-associated macrophages in the tumor microenvironment of cervical cancer.
    Chen XJ; Wu S; Yan RM; Fan LS; Yu L; Zhang YM; Wei WF; Zhou CF; Wu XG; Zhong M; Yu YH; Liang L; Wang W
    Mol Carcinog; 2019 Mar; 58(3):388-397. PubMed ID: 30362630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-1269 promotes proliferation in human hepatocellular carcinoma via downregulation of FOXO1.
    Yang XW; Shen GZ; Cao LQ; Jiang XF; Peng HP; Shen G; Chen D; Xue P
    BMC Cancer; 2014 Dec; 14():909. PubMed ID: 25472505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gα12gep oncogene inhibits FOXO1 in hepatocellular carcinoma as a consequence of miR-135b and miR-194 dysregulation.
    Jung HS; Seo YR; Yang YM; Koo JH; An J; Lee SJ; Kim KM; Kim SG
    Cell Signal; 2014 Jul; 26(7):1456-65. PubMed ID: 24631529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HMGA1 is a novel transcriptional regulator of the FoxO1 gene.
    Arcidiacono B; Chiefari E; Messineo S; Bilotta FL; Pastore I; Corigliano DM; Foti DP; Brunetti A
    Endocrine; 2018 Apr; 60(1):56-64. PubMed ID: 29052178
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.